BIAF
bioAffinity Technologies, Inc. Common Stock
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Best Diagnostics Stocks 2026 →
bioAffinity Technologies (BIAF) Stock: Buy, Sell, or Hold?
$2.34
-0.08 (-3.51%)
▼
5d:
-10.0%
30d:
-34.27%
90d:
+481.94%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (90%)
Quality Score
56/100
Position
OVERSOLD
30-Day Fair Range
$2.42 – $4.68
Position: OVERSOLD
Forward P/E & Valuation
-0.3x
Next 12M consensus est.
Wall Street Target
$6.00
+156.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.23 / $3.22
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: BIAF shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When BIAF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BIAF is currently trading at $2.34, which is considered oversold relative to its 30-day fair value range of $2.42 to $4.68.
Technical Outlook: Technically, BIAF is in a uptrend. Immediate support is located at $2.23, while resistance sits at $3.22. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: BIAF scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.00 (+156.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BIAF is in a uptrend. Immediate support is located at $2.23, while resistance sits at $3.22. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: BIAF scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.00 (+156.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.42 -
$4.68
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$2.42 -
$4.68
Current vs Trading Range
OVERSOLD
Support Level
$2.23
Resistance Level
$3.22
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.5%)
- BULLISH: Trading 156.4% below Wall St target ($6.00)
- CAUTION: Bottoming setup, but lagging the sector by 31% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-10.0%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
-0.29
Wall Street Target
$6.00
(+156.4%)
Revenue Growth (YoY)
19.0%
Profit Margin
-257.3%
Share BIAF Analysis
Share this live BIAF analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BIAF)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
BioAffinity Technologies reported record monthly testing volume for its noninvasive CyPath® Lung Test in October.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:59 PM ET
Data refreshes hourly during market hours. Next update: 10:59 PM
Data refreshes hourly during market hours. Next update: 10:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIAF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 67 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 48 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BIAF Research Pages
